Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Pharmaceutics|July 27, 2022
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast CancerPerrine Courlet, Evelina Cardoso, Carole Bandiera, et al.
Cancers|January 8, 2023
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT StudyCarole Bandiera, Isabella Locatelli, Perrine Courlet, et al.
British Journal of Clinical Pharmacology|March 25, 2021
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trialPerrine Courlet, Charlotte Barbieux, Delphine Sculier, et al.
Cancers|April 15, 2020
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic MelanomaDavid Balakirouchenane, Sarah Guégan, Chantal Csajka, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2023
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapyPerrine Courlet, Daniel Abler, Monia Guidi, et al.
Nature Communications|September 3, 2024
Towards clinically relevant dose ratios for Cabamiquine and Pyronaridine combination using P. falciparum field isolate dataMohamed Maiga, Laurent Dembele, Perrine Courlet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2019
Noninferiority of Simplified Dolutegravir Monotherapy Compared to Continued Combination Antiretroviral Therapy That Was Initiated During Primary Human Immunodeficiency Virus Infection: A Randomized, Controlled, Multisite, Open-label, Noninferiority TrialDominique L Braun, Teja Turk, Fabian Tschumi, et al.
Pageof 3